Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05075603
Title A Study to Evaluate the Safety, Tolerability and Preliminary Anti-tumor Activity of NT-I7 (Efineptakin Alfa) Post-Tisagenlecleucel (Kymriah) in Relapsed/Refractory Large B-cell Lymphoma Subjects
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors NeoImmuneTech
Indications

diffuse large B-cell lymphoma

B-cell lymphoma

Therapies

Tisagenlecleucel

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Recruiting Duarte California 91010 United States Details
Washington University in St. Louis Recruiting Saint Louis Missouri 63110 United States Details
Duke Cancer Institute Recruiting Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field